Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease (vol 160, pg 1741, 2010)

P. J. Austin, M. J. Betts, M. Broadstock, M. J. O'Neill, S. N. Mitchell, S. Duty

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1326-
JournalBritish Journal of Pharmacology
Volume163
Issue number6
DOIs
Publication statusPublished - Jul 2011

Cite this